Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Interest Coverage Ratio (2021 - 2025)

Verrica Pharmaceuticals has reported Interest Coverage Ratio over the past 5 years, most recently at 5.47 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 5.47 for Q4 2025, down 12.68% from a year ago — trailing twelve months through Dec 2025 was 1.57 (up 77.53% YoY), and the annual figure for FY2025 was 1.57, up 77.53%.
  • Interest Coverage Ratio for Q4 2025 was 5.47 at Verrica Pharmaceuticals, down from 0.78 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for VRCA hit a ceiling of 17.88 in Q3 2022 and a floor of 14.43 in Q3 2023.
  • Median Interest Coverage Ratio over the past 5 years was 6.85 (2022), compared with a mean of 5.06.
  • Peak annual rise in Interest Coverage Ratio hit 265.88% in 2022, while the deepest fall reached 11833.64% in 2022.
  • Verrica Pharmaceuticals' Interest Coverage Ratio stood at 7.72 in 2021, then soared by 331.53% to 17.88 in 2022, then tumbled by 156.15% to 10.04 in 2023, then skyrocketed by 51.61% to 4.86 in 2024, then decreased by 12.68% to 5.47 in 2025.
  • The last three reported values for Interest Coverage Ratio were 5.47 (Q4 2025), 0.78 (Q3 2025), and 0.71 (Q2 2025) per Business Quant data.